Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences

About this update from Pacira Biosciences, Inc.

[{"type":"image","alt":"Pacira BioSciences","displaySize":"","headline":null,"caption":"Pacira BioSciences","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/04e0c8f8e2099937e616269a7f79e669"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dRdI2d2CbhpAnNdlbYaSfg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMA--/https://media.zenfs.com/en/globenewswire.com/04e0c8f8e2099937e616269a7f79e669","width":300,"height":300},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/dRdI2d2CbhpAnNdlbYaSfg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMA--/https://media.zenfs.com/en/globenewswire.com/04e0c8f8e2099937e616269a7f79e669","width":300,"height":300}},"lazy":false},{"type":"text","content":"BRISBANE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in analyst-led fireside chats at the following three healthcare conferences:","length":332,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2026 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20th at 8:30AM ET.","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"2026 Jefferies Global Healthcare Conference on Wednesday, June 3rd at 9:55AM ET.","length":80,"tagName":"p"}]},{"val":[{"type":"text","content":"Goldman Sachs 47th Annual Global Healthcare Conference 2026 on Monday, June 8th at 1:20PM ET.","length":93,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":263,"olType":false},{"type":"text","content":"Live audio of the events can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.","length":201,"tagName":"p"},{"type":"text","content":"About Pacira","length":12,"tagName":"p"},{"type":"text","content":"Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve ...

More updates from Pacira Biosciences, Inc.